23andMe Holding Co. (MEHCQ)
OTCMKTS
· Delayed Price · Currency is USD
5.49
+0.34 (6.60%)
Jun 13, 2025, 4:00 PM EDT
23andMe Holding Co. Revenue
In the fiscal year ending March 31, 2025, 23andMe Holding Co. had annual revenue of $189.90M, down -13.54%. 23andMe Holding Co. had revenue of $45.15M in the quarter ending March 31, 2025, a decrease of -29.49%.
Revenue
189.90M
Revenue Growth
-13.54%
P/S Ratio
0.80
Revenue / Employee
332.57K
Employees
582
Market Cap
151.20M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
23andMe Holding Co. News
- 1 day ago - Anne Wojcicki's nonprofit reaches deal to acquire 23andMe - TechCrunch
- 2 days ago - Anne Wojcicki to buy back 23andMe and its data for $305 million - CNBC
- 2 days ago - 23andMe's founder Anne Wojcicki wins bid for bankrupt DNA testing firm - New York Post
- 2 days ago - 23andMe's founder Anne Wojcicki wins bid for DNA testing firm - Reuters
- 2 days ago - 23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process - GlobeNewsWire
- 2 days ago - Anne Wojcicki Wins Bidding for 23andMe - WSJ
- 3 days ago - States take legal action as 23andMe attempts to sell customer genetic information amid bankruptcy - New York Post
- 4 days ago - 23andMe says 15% of customers asked to delete their genetic data since bankruptcy - TechCrunch